Universitas Muhammadiyah Sidoarjo
Login


Indonesian Journal on Health Science and Medicine

 Submit manuscript
Section Articles

Novel Biomarkers for Early Detection of Bacterial Meningitis

Penanda Biologis Baru untuk Deteksi Dini Meningitis Bakteri
Vol. 2 No. 2 (2025): Oktober:
DOI : https://doi.org/10.21070/ijhsm.v2i2.264
Published : Sep 23, 2025

Ahmed Kadhim Hommood (1)

(1) Shatrah University, College of Education for Girls, Iraq
Fulltext View | Download

Abstract:

General Background: Bacterial meningitis is a life-threatening disease that demands rapid and accurate diagnosis to reduce morbidity and mortality. Specific Background: Conventional methods such as CSF culture, Gram staining, and biochemical tests often lack sensitivity, specificity, or require long processing time, limiting their usefulness in urgent clinical settings. Knowledge Gap: There remains limited evidence on the comparative diagnostic accuracy of novel biomarkers against routine laboratory parameters in early bacterial meningitis detection. Aims: This study aimed to evaluate the diagnostic value of Procalcitonin (PCT), Interleukin-6 (IL-6), and C-Reactive Protein (CRP) for early identification of bacterial meningitis compared to conventional laboratory markers. Results: Conducted as a case-control study in Iraq involving 100 patients and 50 controls, the findings showed significantly elevated serum levels of PCT, IL-6, and CRP in patients (p < 0.001). PCT demonstrated the highest diagnostic accuracy (AUC = 0.95), followed by IL-6 (0.93) and CRP (0.90), with all biomarkers correlating strongly with disease severity. Novelty: The study highlights PCT and IL-6 as highly reliable early diagnostic tools that surpass traditional parameters. Implications: Incorporating these biomarkers into diagnostic protocols can facilitate earlier interventions, improve monitoring, and reduce long-term complications in bacterial meningitis.
Highlight :




  • Procalcitonin has the strongest diagnostic value.




  • IL-6 and CRP are reliable indicators of severity.




  • Biomarkers support timely and accurate detection.




Keywords : Bacterial Meningitis, Procalcitonin, Interleukin-6, C-Reactive Protein, Early Diagnosis

References

J. M. Baran, A. Porebska, and M. Lesisz, “Investigating Blood Biomarkers That Can Facilitate the Diagnosis of Meningitis—A Systematic Literature Review,” Int. J. Mol. Sci., vol. 26, no. 3, pp. 1–15, 2025, doi: 10.3390/ijms26030123.

N. S. Groeneveld, M. W. Bijlsma, D. van de Beek, et al., “Biomarkers in Paediatric Bacterial Meningitis: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy,” Clin. Microbiol. Infect., vol. 31, no. 2, pp. 145–156, 2025, doi: 10.1016/j.cmi.2024.11.005.

T. T. Thanh, C. Casals-Pascual, N. T. H. Ny, N. M. Ngoc, et al., “Value of Lipocalin 2 as a Potential Biomarker for Bacterial Meningitis,” Clin. Microbiol. Infect., vol. 27, no. 6, pp. 915–922, 2021, doi: 10.1016/j.cmi.2020.12.004.

C. M. Manyelo, R. S. Solomons, G. Walzl, et al., “Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches,” J. Clin. Microbiol., vol. 59, no. 4, pp. e02882-20, 2021, doi: 10.1128/JCM.02882-20.

V. Ecesoy and H. Ecesoy, “Is Procalcitonin Elevation Always an Indicator of Bacterial Infection?,” Arch. Rheumatol., vol. 39, no. 1, pp. 123–126, 2024. [Online]. Available: [https://archivesofrheumatology.org](https://archivesofrheumatology.org)

H. Shahzad, A. J. Khokhar, S. Ibrahim, and M. U. Farooq, “High Procalcitonin Does Not Always Indicate a Bacterial Infection,” Cureus, vol. 16, no. 2, pp. e31234, 2024, doi: 10.7759/cureus.31234.

Y. Chen, J. Shen, H. Yang, S. Xu, Y. Ma, and F. Pan, “Serum Procalcitonin and C-Reactive Protein Levels as Diagnostic Markers for Distinguishing Bacterial Infections From Lupus Flares in Systemic Lupus Erythematosus,” Int. Immunopharmacol., vol. 96, pp. 107597, 2021, doi: 10.1016/j.intimp.2021.107597.

T. Wasilewski, W. Kamysz, and J. Gebicki, “AI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring,” Biosensors, vol. 14, no. 5, pp. 205, 2024, doi: 10.3390/bios14050205.

H. Y. Wang, W. Y. Lin, C. Zhou, Z. A. Yang, S. Kalpana, et al., “Integrating Artificial Intelligence for Advancing Multiple-Cancer Early Detection via Serum Biomarkers: A Narrative Review,” Cancers, vol. 16, no. 2, pp. 423, 2024, doi: 10.3390/cancers16020423.

E. Castagno, S. Aguzzi, L. Rossi, and R. Gallo, “Clinical Predictors and Biomarkers in Children With Sepsis and Bacterial Meningitis,” Pediatr. Emerg. Care, vol. 39, no. 1, pp. 45–52, 2023, doi: 10.1097/PEC.0000000000002751.

A. Al-Mekhlafi, K. W. Suhs, S. Schuchardt, M. Kuhn, et al., “Elevated Free Phosphatidylcholine Levels in Cerebrospinal Fluid Distinguish Bacterial From Viral CNS Infections,” Cells, vol. 10, no. 11, pp. 3103, 2021, doi: 10.3390/cells10113103.

Z. A. A. Arafa, M. S. Gabr, E. M. Kamel, and S. A. ElMasry, “Cerebrospinal Fluid Lactate as a Differential Biomarker for Bacterial and Viral Meningitis,” Egypt. J. Immunol., vol. 30, no. 2, pp. 33–42, 2023.

M. H. Gronhoj, T. Sejbaek, R. W. Hansen, L. Larsen, et al., “Serum Levels of Neurofilament Light Chain, Neuron-Specific Enolase and S100 Calcium-Binding Protein B During Acute Bacterial Meningitis: A Prospective Cohort Study,” Infect. Dis., vol. 53, no. 9, pp. 697–705, 2021, doi: 10.1080/23744235.2021.1924138.

M. Shi, Y. Wei, H. Huang, R. Guo, et al., “Heparin-Binding Protein Levels as an Emerging Key Biomarker for Accurate Diagnosis of Bacterial Meningitis: A Promising Yet Preliminary Evaluation,” Microb. Pathog., vol. 180, pp. 106037, 2025, doi: 10.1016/j.micpath.2023.106037.

T. M. van Soest, N. Chekrouni, and N. M. van Sorge, “Bacterial Meningitis Presenting With a Normal Cerebrospinal Fluid Leukocyte Count,” J. Infect., vol. 85, no. 4, pp. 377–384, 2022, doi: 10.1016/j.jinf.2022.07.004.

R. Hasbun, “Progress and Challenges in Bacterial Meningitis: A Review,” JAMA, vol. 328, no. 5, pp. 442–450, 2022, doi: 10.1001/jama.2022.9824.

S. Dyckhoff-Shen, J. P. Bewersdorf, N. C. Teske, and S. Volk, “Characterization and Diagnosis Spectrum of Patients With Cerebrospinal Fluid Pleocytosis,” Infection, vol. 52, no. 2, pp. 273–282, 2024, doi: 10.1007/s15010-023-02050-0.

H. Kim, Y. H. Roh, and S. H. Yoon, “Blood Procalcitonin Level as a Diagnostic Marker of Pediatric Bacterial Meningitis: A Systematic Review and Meta-Analysis,” Diagnostics, vol. 11, no. 7, pp. 1194, 2021, doi: 10.3390/diagnostics11071194.

Y. C. Lee, H. T. Yeh, S. W. Lu, Y. C. Tsai, and Y. C. Tsai, “Diagnostic Accuracy of Procalcitonin in Adult Non-Neutropenic Cancer Patients With Suspected Infection: A Systematic Review and Meta-Analysis,” BMC Infect. Dis., vol. 24, no. 1, pp. 82, 2024, doi: 10.1186/s12879-024-09345-7.

Q. Li, S. Zheng, P. Y. Zhou, Z. Xiao, et al., “The Diagnostic Accuracy of Procalcitonin in Infectious Patients After Cardiac Surgery: A Systematic Review and Meta-Analysis,” J. Thorac. Dis., vol. 13, no. 8, pp. 4921–4933, 2021, doi: 10.21037/jtd-21-234.

M. Tao, D. Zheng, X. Liang, Q. He, et al., “Diagnostic Value of Procalcitonin for Bacterial Infections in Patients Undergoing Hemodialysis: A Systematic Review and Meta-Analysis,” Ren. Fail., vol. 44, no. 1, pp. 1245–1256, 2022, doi: 10.1080/0886022X.2022.2101074.

Y. H. Huang, C. J. Chen, S. C. Shao, and C. H. Li, “Comparison of the Diagnostic Accuracies of Monocyte Distribution Width, Procalcitonin, and C-Reactive Protein for Sepsis: A Systematic Review and Meta-Analysis,” Crit. Care, vol. 27, no. 1, pp. 345, 2023, doi: 10.1186/s13054-023-04617-8.

S. Dutta, N. Sachdeva, and A. Pal, “Cerebrospinal Fluid and Plasma Procalcitonin for the Diagnosis of Neonatal Bacterial Meningitis,” J. Paediatr. Child Health, vol. 58, no. 6, pp. 1002–1008, 2022, doi: 10.1111/jpc.16054.

A. P. Nugrahanto, A. Triono, R. A. Damroni, et al., “Diagnostic Value of Serum Procalcitonin, CSF Neutrophil-to-Lymphocyte Ratio, and CSF Lactate in Pediatric Bacterial Meningoencephalitis,” Ann. Indian Acad. Neurol., vol. 27, no. 2, pp. 215–221, 2024, doi: 10.4103/aian.aian_85_23.

A. M. Nawara, M. M. M. El Saeed, and D. M. Abdelmon, “Diagnostic Value of Cerebrospinal Fluid Procalcitonin in Differentiating Bacterial and Aseptic Meningitis: A Cross-Sectional Study,” Univ. Med., vol. 44, no. 1, pp. 33–40, 2025, doi: 10.18051/UnivMed.2025.v44.33-40.

H. G. Xu, M. Tian, and S. Y. Pan, “Clinical Utility of Procalcitonin and Its Association With Pathogenic Microorganisms,” Crit. Rev. Clin. Lab. Sci., vol. 59, no. 7, pp. 467–481, 2022, doi: 10.1080/10408363.2021.1972375.

A. Pant, I. Mackraj, and T. Govender, “Advances in Sepsis Diagnosis and Management: A Paradigm Shift Towards Nanotechnology,” J. Biomed. Sci., vol. 28, no. 1, pp. 35, 2021, doi: 10.1186/s12929-021-00742-y.

J. Fu, W. Cai, S. Pan, L. Chen, et al., “Developments and Trends of Nanotechnology Application in Sepsis: A Comprehensive Review Based on Knowledge Visualization Analysis,” ACS Nano, vol. 18, no. 2, pp. 1253–1271, 2024, doi: 10.1021/acsnano.3c08056.

E. W. Woodhouse, M. T. McClain, et al., “Harnessing the Host Response for Precision Infectious Disease Diagnosis,” Clin. Microbiol. Rev., vol. 37, no. 1, pp. e00015-23, 2024, doi: 10.1128/CMR.00015-23.